Arrowhead Pharmaceuticals, Inc. has grown revenue 38% a year over three years and 44% a year over five. Revenue growth, 3-year annual rate: +38% (Biotechnology median +17%). Revenue growth, 5-year rate: +44%, growth has slowed since the five-year average. Years of annual history on file: 23, FY2003 to FY2025, as filed.

ARWRArrowhead Pharmaceuticals, Inc.

Healthcare

$62.78+105% 1Y

$62.78

$31.6652 weeks$89.61

Is it growing?

Good

Growing: revenue growing +17% year on year and operating margin widening (+1187.3 points).

2 good, 1 without data

Revenue trend+17% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +44% a year.

Margin direction+1187.3 points operating

Trailing-twelve-month operating margin, -96.2% now against -1283.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ARWR growing?

Arrowhead Pharmaceuticals, Inc. has grown revenue 38% a year over three years and 44% a year over five.

+38%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +44%
Revenue growth, 5-year rate · +38% over three · growth has slowed since the five-year average
Years of annual history on file: 23
Years of annual history on file · FY2003 to FY2025, as filed

Details›